Web1 day ago · Photocure ASA: Annual Report 2024 PR Newswire OSLO, Norway , April 12, 2024 /PRNewswire/ -- Photocure ASA today announces the publication of the Annual Report and integrated ESG report for 2024. ... For more information, please visit us at www.photocure.com , www.hexvix.com or www.cysview.com . All trademarks … WebApr 12, 2024 · For more information, please visit us at www.photocure.com, www.hexvix.com or www.cysview.com. This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act. Share this article. News and events. OSE Notice. Photocure ASA: Annual Report 2024.
Bladder Cancer technology: New improved Blue Light
WebHexaminolevulinate, sold under the brand names Cysview and Hexvix, is an imaging agent that lights up under blue light during a blue light cystoscopy.It is used to help detect non-muscle invasive bladder cancer (NMIBC), in particular papillary tumors and carcinoma in situ (CIS).. It made by Photocure ASA, a Norwegian pharmaceutical company.. References WebApr 12, 2024 · Photocure CFO Erik Dahl Tel: +47 450 55 000 Email: [email protected]. About Photocure ASA: Photocure: The Bladder Cancer Company delivers transformative solutions to improve the lives of bladder cancer patients. Our unique technology, making cancer cells glow bright pink, has led to better health outcomes for patients worldwide. pontipine house
Photocure Announces the Commercial Availability of Karl Storz’s …
WebMar 21, 2024 · As previously disclosed by Photocure, Cysview sales resulting from new flexible BLC tower installations were expected to represent less than 2% of total Company revenues in FY 2024. There are currently 69 flexible BLC towers in the U.S. Photocure will continue to focus on expanding the installed base of rigid BLC in the U.S. and on … WebAug 25, 2024 · Photocure is commercializing Cysview/Hexvix directly in the U.S. and Europe, and has strategic partnerships for the commercialization of Hexvix/Cysview in … WebAug 10, 2024 · OSLO, Norway, Aug. 10, 2024 /PRNewswire/ -- Photocure ASA (OSE:PHO) today reported Hexvix®/Cysview® revenues of NOK 99.9 million in the second quarter of 2024 (Q1 2024: NOK 88.9 million), and a... pont international